// App-Quantinova.ai

PO0421 : Clinical Characteristics and eGFR and Urine Albumin-to-Creatinine Ratio Distribution According to the 2012 KDIGO CKD Classification: A Report from the DISCOVER CKD International Retrospective Cohort

Researchers

Presenter

  • Garcia Sanchez Juan Jose

Principal Investigators

  • Carrero JuanJesus

  • Kumar SupriyaR

  • Pecoits-Filho Roberto

  • James Glen

  • L Heerspink HiddoJan

  • Nolan Stephen

  • Carolyn LamSu ping

  • Chen Hungta (tony)

  • Kanda Eiichiro

  • Abdul Sultan Alyshah

  • Kashihara Naoki

  • Kosiborod Mikhail

  • Pollock CarolA

  • Wheeler DavidC

Medical Centers

  • Astra Zeneca, Cambridge, United Kingdom

  • Karolinska Institutet, Stockholm, Stockholms Lan, Sweden

  • AstraZeneca Gaithersburg Maryland United States

  • Arbor Research Collaborative for Health, Ann Arbor, United States of America

  • Rijksuniversiteit Groningen, Groningen, Netherlands

  • National Cancer Centre Singapore, Singapore, Singapore

  • Kawasaki Ika Daigaku Kurashiki Okayama Japan

  • St Lukes Mid America Heart Institute Kansas City Kansas United States

  • Royal Northshore Hospital, St Leonards, New South Wales, Australia

  • Kings College London, London, United Kingdom

Locations

  • United Kingdom

  • Sweden

  • United States

  • Netherlands

  • Singapore

  • Japan

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • End stage renal disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved